ADPT news

Latest 2 stories · newest Jun 22, 2026

ADPT

Adaptive Biotechnologies issues 0% convertible senior notes due 2031

Adaptive Biotechnologies Corporation entered into an indenture with U.S. Bank Trust Company for 0% convertible senior notes due 2031, dated June 22, 2026. This debt offering provides the company with capital financing while offering investors conversion rights to equity.

Offering Jun 22, 2026 sentiment 0.00 SEC filing ↗

ADPT

Adaptive Biotechnologies proposes $250M convertible senior notes offering due 2031

Adaptive Biotechnologies announced a proposed $250 million convertible senior notes offering to repay OrbiMed obligations and fund stock repurchases. Proceeds will enhance financial flexibility and support general corporate purposes and MRD business initiatives.

Offering Jun 15, 2026 sentiment +0.15 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same ADPT feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/ADPT/newsSTART FREE